IGM Biosciences Inc. (IGMS) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts IGMS Hot Sheet
Join SI Premium – FREE
IGM Biosciences Inc. (NASDAQ: IGMS) reported Q2 EPS of ($1.43), $0.03 worse than the analyst estimate of ($1.40). Revenue for the quarter came in at $450 thousand versus the consensus estimate of $797 thousand.
For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
